JP2023532223A5 - - Google Patents
Info
- Publication number
- JP2023532223A5 JP2023532223A5 JP2022577794A JP2022577794A JP2023532223A5 JP 2023532223 A5 JP2023532223 A5 JP 2023532223A5 JP 2022577794 A JP2022577794 A JP 2022577794A JP 2022577794 A JP2022577794 A JP 2022577794A JP 2023532223 A5 JP2023532223 A5 JP 2023532223A5
- Authority
- JP
- Japan
- Prior art keywords
- immediate
- release tablet
- tablet according
- weight
- patient
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063041403P | 2020-06-19 | 2020-06-19 | |
| US63/041,403 | 2020-06-19 | ||
| US202063043292P | 2020-06-24 | 2020-06-24 | |
| US63/043,292 | 2020-06-24 | ||
| PCT/EP2021/066386 WO2021255159A1 (en) | 2020-06-19 | 2021-06-17 | Formulation comprising daprodustat |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023532223A JP2023532223A (ja) | 2023-07-27 |
| JP2023532223A5 true JP2023532223A5 (cg-RX-API-DMAC7.html) | 2024-06-18 |
| JP7797425B2 JP7797425B2 (ja) | 2026-01-13 |
Family
ID=76730508
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022577794A Active JP7797425B2 (ja) | 2020-06-19 | 2021-06-17 | ダプロデュスタットを含んでなる処方物 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20230225977A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4167967A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7797425B2 (cg-RX-API-DMAC7.html) |
| CN (1) | CN115697307A (cg-RX-API-DMAC7.html) |
| BR (1) | BR112022024533A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3180509A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2021255159A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20240228443A1 (en) * | 2021-06-18 | 2024-07-11 | Glaxosmithkline Intellectual Property (No.2) Limited | Novel manufacturing method of daprodustat and precursors thereof |
| WO2024257063A1 (en) * | 2023-06-16 | 2024-12-19 | Glenmark Life Sciences Limited | Solid dispersion of daprodustat and a process for the preparation thereof |
| KR20260061246A (ko) * | 2023-10-24 | 2026-05-06 | 카인드 파마슈티컬 | 저산소증 유도인자-프로릴히드록시라제 억제제를 함유하는 장시간 작용형 경구 의약품 및 그 사용 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI394747B (zh) | 2006-06-23 | 2013-05-01 | Smithkline Beecham Corp | 脯胺醯基羥化酶抑制劑 |
| CN101773498B (zh) * | 2009-12-30 | 2012-06-20 | 青岛黄海制药有限责任公司 | 一种含有非布司他的口服缓控释制剂的制备方法 |
| NZ735973A (en) * | 2015-04-01 | 2023-06-30 | Akebia Therapeutics Inc | Compositions and methods for treating anemia |
| TWI804919B (zh) * | 2015-06-30 | 2023-06-11 | 美商建南德克公司 | 含藥物之立即釋放錠劑及形成該錠劑的方法 |
| RU2736941C2 (ru) * | 2015-12-02 | 2020-11-23 | Мерк Шарп энд Доум Корп. | Фармацевтические композиции, содержащие доравирин, тенофовира дизопроксила фумарат и ламивудин |
| CA2937365C (en) * | 2016-03-29 | 2018-09-18 | F. Hoffmann-La Roche Ag | Granulate formulation of 5-methyl-1-phenyl-2-(1h)-pyridone and method of making the same |
| PH12018000227B1 (en) * | 2017-09-05 | 2019-03-11 | Frimline Private Ltd | A pharmaceutical composition for improving or preventing progression of chronic kidney disease |
| AU2018330994A1 (en) * | 2017-09-15 | 2020-04-16 | GlaxoSmithKline Intellectual Property (No. 2) Limited, England | Crystalline forms of gsk1278863, preparation method and pharmaceutical use thereof |
| CN111278433A (zh) * | 2017-09-26 | 2020-06-12 | 特沙诺有限公司 | 尼拉帕尼制剂 |
| CN112955130A (zh) * | 2018-10-30 | 2021-06-11 | 佩洛通治疗公司 | 包含取代茚满的固体分散体和药物组合物及其制备和使用方法 |
| EP3880663A1 (en) * | 2018-11-15 | 2021-09-22 | Teva Pharmaceuticals International GmbH | Solid state forms of daprodustat and process for preparation thereof |
-
2021
- 2021-06-17 CN CN202180043608.0A patent/CN115697307A/zh active Pending
- 2021-06-17 CA CA3180509A patent/CA3180509A1/en active Pending
- 2021-06-17 EP EP21736531.1A patent/EP4167967A1/en active Pending
- 2021-06-17 BR BR112022024533A patent/BR112022024533A2/pt not_active Application Discontinuation
- 2021-06-17 WO PCT/EP2021/066386 patent/WO2021255159A1/en not_active Ceased
- 2021-06-17 JP JP2022577794A patent/JP7797425B2/ja active Active
- 2021-06-17 US US18/010,245 patent/US20230225977A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5798269B2 (ja) | 薬物高含量錠剤 | |
| KR101667762B1 (ko) | 엔타카폰 또는 이의 염의 서방형 약학 조성물 | |
| TWI724993B (zh) | C-met抑制劑的錠劑配方 | |
| JP2021512117A5 (cg-RX-API-DMAC7.html) | ||
| CN104220068B (zh) | 包含奥美沙坦酯和罗苏伐他汀或其盐的药物组合物 | |
| FI3804716T3 (fi) | Farmaseuttinen yhdistelmä, koostumus ja yhdistelmävalmiste, joka käsittää glukokinaasin aktivaattorin ja sglt-2:n estäjän ja niiden valmistusmenetelmiä ja käyttöjä | |
| JP2015506377A5 (cg-RX-API-DMAC7.html) | ||
| JP2017537899A5 (cg-RX-API-DMAC7.html) | ||
| TWI848241B (zh) | 1-(3-氰基-1-異丙基-吲哚-5-基)吡唑-4-羧酸結晶之製備方法及包含彼之醫藥組成物 | |
| JP2019523258A (ja) | エソメプラゾール、又は薬学的に許容可能なその塩を含むpH依存性薬物放出特性が改善した剤形 | |
| JP2003535895A5 (cg-RX-API-DMAC7.html) | ||
| JP7797425B2 (ja) | ダプロデュスタットを含んでなる処方物 | |
| KR20180135020A (ko) | 니코틴아미드의 경구 약제학적 조성물 | |
| WO2019142207A1 (en) | Pharmaceutical compositions comprising ibrutinib | |
| WO2010017310A1 (en) | Method for the treatment of acne and certain dosage forms thereof | |
| JP2023548855A5 (cg-RX-API-DMAC7.html) | ||
| WO2023211412A1 (en) | A tablet comprising sacubitril and valsartan processed with dry granulation | |
| WO2018211336A2 (en) | Solid dosage form containing sorafenib tosylate | |
| EP4268806A1 (en) | A tablet comprising sacubitril and valsartan processed with dry granulation | |
| JP2025508402A5 (cg-RX-API-DMAC7.html) | ||
| WO2013169218A1 (en) | Pharmaceutical compositions of s-etodolac | |
| CN105232551A (zh) | 一种缬沙坦/苯磺酸氨氯地平复方制剂及其制备方法 | |
| KR102330953B1 (ko) | 소듐-1-[6-(모르폴린-4-일)피리미딘-4-일]-4-(1h-1,2,3-트리아졸-1-일)-1h-피라졸-5-올레이트를 함유하는 제약 투여 형태 | |
| WO2014068507A1 (en) | Solid oral pharmaceutical compositions of telmisartan, essentially free of surfactants | |
| WO2014159275A1 (en) | Controlled-release pharmaceutical compositions comprising lamotrigine and methods of producing same |